Stabilization Phase Sample Clauses

Stabilization Phase. The program will begin with purchases of a range of Eligible IG ETFs and Eligible HY ETFs, with the preponderance of purchases in Eligible IG ETFs. Operational readiness to purchase Eligible Bonds is expected to follow shortly after operational readiness to purchase Eligible ETFs.2 • Purchases will be focused on reducing the broad-based deterioration of liquidity seen in March 2020 to levels that correspond more closely to prevailing economic conditions. • Purchases made in this phase will generally be made at a higher pace than will occur in the ongoing monitoring phase described below, with the goal of pushing market functioning 1 If signs of improvement in market functioning are observed, purchases should take place towards the lower end of the range of percentages of average daily volume. If signs of deterioration in market functioning are observed, purchases should take place towards the higher end of the range of percentages of average daily volume.
Sample 1Sample 2
AutoNDA by SimpleDocs
Stabilization Phase. 21 3.1 OBJECTIVE..................................................... 21 3.2 SOLUTION INITIATIVES - GLOBAL PROJECTS........................ 21 3.3
Sample 1Sample 2
Stabilization Phase. An STA enters the Stabilization Phase after each of three antecedent conditions: (1) once flow-through operations begin following the initial start-up of a new treatment cell; (2) when a treatment cell is taken off-line for implementation of Long-Term Plan enhancements that may have adverse impacts on STA performance, or (3) when a treatment cell is taken off-line for recovery activities associated with a major event that compromises the structural integrity or performance of the STA. During the Stabilization Phase the treatment vegetation will be maturing and the STA performance will generally be improving toward achieving the TBEL. However, the overall performance of the STA is extremely difficult to predict due to inherent variability of individual cells/flow-ways coming on and off-line. It is anticipated that the treatment vegetation will require one to three years after flow- through operations begin for the affected cells to achieve optimal performance. During the stabilization phase the Department has determined that the TBEL shall apply.
Sample 1
Stabilization Phase. (6 to 12 weeks)
Sample 1
Stabilization Phase. Once flow-through operations begin for Cell 4, and again when Cells 1 and 2 are taken off-line for implementation of Long-Term Plan enhancements, the STA will enter the Stabilization Phase. During the Stabilization Phase, the overall performance of the STA is extremely difficult to predict. After Cell 4 begins flow-through operations and before Cells 1 and 2 is taken off-line for enhancements, the STA performance should generally improve as the inflow loads are distributed over four treatment cells, however, this is dependent on the performance of Cell 4 which is impossible to predict. During the construction of enhancements in Cells 1 and 2, there will be a period when only 3 flow-ways will be on-line. This will be followed by a period when Cells 1 and 2 will be in flow-through operation but prior to the treatment vegetation achieving optimal performance. The treatment cells being converted to SAV may require 2-3 years after flow-through operations begin to achieve optimal performance. The Stabilization Phase ends when the STA is achieving the TBEL.
Sample 1

Related to Stabilization Phase

  • Stabilization Neither the Company nor, to its knowledge, any of its employees, directors or shareholders (without the consent of the Representative) has taken or shall take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Public Securities.

  • Stabilization and Over-Allotment In order to facilitate the sale of the Securities, we authorize you, in your discretion, to purchase and sell Securities or any other securities of the Issuer or any guarantor of the Securities specified in the Invitation in the open market or otherwise, for long or short account, at such prices as you may determine, and, in arranging for sales to Selected Dealers or others, to over-allot. You may liquidate any long position or cover any short position incurred pursuant to this Section as such prices as you may determine. You shall make such purchases and sales (including over-allotments) for the accounts of the Underwriters as nearly as practicable in proportion to their respective underwriting obligations. It is understood that, in connection with any particular offering of Securities to which this Agreement applies, you may have made purchases of securities of the Issuer or securities of any guarantor of the Securities for stabilizing purposes prior to the time when we become an Underwriter, and we agree that any such securities so purchased shall be treated as having been purchased for the respective accounts of the Underwriters pursuant to the foregoing authorization. At the close of business on any day our net commitment, either for long or short account, resulting from such purchases or sales (including over-allotments) shall not exceed 20% (or such other amount as may be specified in the Invitation) of our underwriting obligation, except that such percentage may be increased with the approval of a majority in interest of the Underwriters. We will take up at cost on demand any Securities or other securities of the Issuer or any securities of any guarantor of the Securities so sold or over-allotted for our account, including accrued interest, amortization of original issue discount or dividends, and we will pay to you on demand the amount of any losses or expenses incurred for our account pursuant to this Section. In the event of default by any Underwriter in respect of its obligations under this Section, each non-defaulting Underwriter shall assume its share of the obligations of such defaulting Underwriter in the proportion that its underwriting obligation bears to the underwriting obligations of all non-defaulting Underwriters without relieving such defaulting Underwriter of its liability hereunder. If you effect any stabilizing purchase pursuant to this Section, you shall promptly notify us of the date and time of the first stabilizing purchase and the date and time when stabilizing was terminated. You shall prepare and maintain such records as are required to be maintained by you as manager pursuant to Rule 17a-2 under the 1934 Act.

  • Stabilization and Manipulation Neither the Adviser, the Administrator nor any of their respective partners, officers, affiliates or controlling persons has taken, directly or indirectly, any action designed, under the 1934 Act, to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale of the Securities in violation of any law, statute, regulation or rule applicable to the Adviser, the Administrator or any of their respective partners, officers, affiliates or controlling persons.

  • No Stabilization The Company has not taken, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Shares.

  • Market Stabilization In connection with the distribution of the Offered Shares, the Underwriters (or any of them) may effect transactions which stabilize or maintain the market price of the Common Shares at levels other than those which might otherwise prevail in the open market, but in each case as permitted by Applicable Securities Laws. Such stabilizing transactions, if any, may be discontinued by the Underwriters at any time.

  • No Price Stabilization or Manipulation The Company has not taken and will not take, directly or indirectly, any action designed to, or that might be reasonably expected to cause or result in, stabilization or manipulation of the price of any securities of the Company to facilitate the sale or resale of the Offered Securities.

  • No Stabilization or Manipulation; Compliance with Regulation M The Company will not take, and will ensure that no affiliate of the Company will take, directly or indirectly, any action designed to or that might cause or result in stabilization or manipulation of the price of the Shares or any reference security with respect to the Shares, whether to facilitate the sale or resale of the Offered Shares or otherwise, and the Company will, and shall cause each of its affiliates to, comply with all applicable provisions of Regulation M.

  • No Price Stabilization Neither the Company nor any of the Subsidiaries nor, to the Company’s knowledge, any of their respective officers, directors, affiliates or controlling persons has taken or will take, directly or indirectly, any action designed to cause or result in, or which has constituted or which might reasonably be expected to constitute the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!